Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal vs Intravenous Fentanyl for Pre-hospital Pain
NCT00882960Phase 4Unknown
- Sponsor
- Genesys Biotech
- Start
- Apr 2009
- Primary completion
- Apr 2012
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of fentanyl citrate nasal spray in pain (2 arms), sponsored by Genesys Biotech. Primary endpoint: Change in Subjective Pain Score at 10 months. Status: unknown.
02
Drugs
fentanyl citrate nasal spray
03
Conditions
pain
Beyond the preview
Go deeper on NCT00882960.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00882960.